Sartorius Stedim Biotech S.A. (SRTOY) Investment Research Dashboard
About Sartorius Stedim Biotech S.A. (SRTOY) stock analysis
Get live SRTOY stock price $19.16, comprehensive Sartorius Stedim Biotech S.A. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SRTOY stock data and investment insights.
Loading chart data...
Sartorius Stedim Biotech S.A. (SRTOY) Overview
Sartorius Stedim Biotech S.A. (SRTOY) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, SRTOY trades at $19.16 with a market capitalization of 186.36B . Over the past 52 weeks, SRTOY has traded between $17.25 and $26.54 , with the current price positioned at approximately 21% of this rang...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 186.36B
- Current price: $19.16
- 52-week range: $17.25 - $26.54
- P/E ratio: 99.56
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sartorius Stedim Biotech S.A. operates globally, providing essential instruments and consumables to the biopharmaceutical industry. Their product range is extensive, featuring items such as cell lines, cell culture growth media, and bioreactors. The ...
Company Information
- CEO
- Rene Faber
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 10456
Contact Information
- Website
- https://www.sartorius.com
- Address
- Zone Industrielle Les Paluds
- Country
- FR
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 186.4 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 99.6)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sartorius Stedim Biotech S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sartorius Stedim Biotech S.A.
- ⚠Investors should consider how Sartorius Stedim Biotech S.A. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 99.6) requires strong growth to justify
Market Cap
186.36B
P/E Ratio (TTM)
99.56
Beta
1.15
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SRTOY with peer companies:
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $190.80-1.50% (1D)
- Market cap
- 88.56B
- Price
- $97.00+2.72% (1D)
- Market cap
- 89.16B
- Price
- $12.71+0.47% (1D)
- Market cap
- 114.54B
- Price
- $50.00+1.78% (1D)
- Market cap
- 222.14B
- Price
- $150.00-2.89% (1D)
- Market cap
- 285.11B
- Price
- $448.19+3.03% (1D)
- Market cap
- 357.10B
- Price
- $56.52+3.20% (1D)
- Market cap
- 360.27B
- Price
- $450.50+2.39% (1D)
- Market cap
- 310.36B
- Price
- $50.82+3.50% (1D)
- Market cap
- 74.25B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.